Unknown

Dataset Information

0

Fluorescence lifetime imaging to investigate propofol-induced metabolic alterations in MDA-MB-231 cells.

ABSTRACT: The metabolic effects of anesthetic agents like propofol on cancer cells remain poorly understood despite the widespread use of anesthesia during cancer diagnosis and treatment. Fluorescence lifetime imaging microscopy (FLIM) was used to analyze propofol-induced metabolic changes in triple-negative breast cancer cells (MDA-MB-231) by monitoring endogenous NAD(P)H and FAD fluorescence lifetimes. FLIM of propofol-treated MDA-MB-231 cells revealed concentration-dependent shifts in metabolic states that were supported by Seahorse extracellular flux analysis. While the flux analysis provided population-averaged metabolic data, FLIM enabled high-resolution, dynamic mapping of metabolism in live cancer cells. Our study highlights FLIM as a label-free tool for investigating anesthetic-induced metabolic alterations in cells, offering insights into the potential metabolic mechanisms of propofol.

SUBMITTER: Tasmi TA 

PROVIDER: S-EPMC12642986 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Fluorescence lifetime imaging to investigate propofol-induced metabolic alterations in MDA-MB-231 cells.

Tasmi Tabassum Ahmad TA   Singh Lakhvir L   Walsh Alex J AJ  

Biomedical optics express 20251020 11

The metabolic effects of anesthetic agents like propofol on cancer cells remain poorly understood despite the widespread use of anesthesia during cancer diagnosis and treatment. Fluorescence lifetime imaging microscopy (FLIM) was used to analyze propofol-induced metabolic changes in triple-negative breast cancer cells (MDA-MB-231) by monitoring endogenous NAD(P)H and FAD fluorescence lifetimes. FLIM of propofol-treated MDA-MB-231 cells revealed concentration-dependent shifts in metabolic states  ...[more]

Similar Datasets

Unknown Low-Symmetry Mixed Fluorinated Subphthalocyanines as Fluorescence Imaging Probes in MDA-MB-231 Breast Tumor Cells.
| S-EPMC5486000 | biostudies-literature
Unknown Effects of FSTL1 on cell proliferation in breast cancer cell line MDA‑MB‑231 and its brain metastatic variant MDA‑MB‑231‑BR.
| S-EPMC5780039 | biostudies-literature
Unknown Citral induced apoptosis in MDA-MB-231 spheroid cells.
| S-EPMC5809808 | biostudies-literature
Unknown GC/MS analysis of hypoxic volatile metabolic markers in the MDA-MB-231 breast cancer cell line.
| S-EPMC10210155 | biostudies-literature
Unknown Shock wave impact on the viability of MDA-MB-231 cells.
| S-EPMC7272042 | biostudies-literature
Unknown Elastin molecular aging promotes MDA-MB-231 breast cancer cell invasiveness.
| S-EPMC6120250 | biostudies-literature
Unknown Synthesis of the C3 and C1 Constitutional Isomers of Trifluorosubphthalocyanine and Their Fluorescence within MDA-MB-231 Breast Tumor Cells.
| S-EPMC6864546 | biostudies-literature
Unknown Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging.
| S-EPMC9415040 | biostudies-literature
Unknown Pharmaceutical characterization and exploration of Arkeshwara rasa in MDA-MB-231 cells.
| S-EPMC10792653 | biostudies-literature
Unknown Amikacin Suppresses Human Breast Cancer Cell MDA-MB-231 Migration and Invasion.
| S-EPMC7712503 | biostudies-literature